Article Text

Download PDFPDF
Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis
  1. Ricardo Alberto Mosquera1,
  2. Lila Estrada2,
  3. Roya Mohebpour Clements2,
  4. Cindy K Jon1
  1. 1Department of Pediatric Pulmonology, The University of Texas Health Science Center at Houston, Houston, Texas, USA
  2. 2The University of Texas Health Science Center at Houston, Houston, Texas, USA
  1. Correspondence to Dr Ricardo Alberto Mosquera, ricardo.a.mosquera{at}


Invasive pulmonary aspergillosis is a rare and fatal complication in patients with cystic fibrosis (CF) who lack concomitant risk factors. The few documented cases in children have all resulted in deaths during hospitalisation. We present the case of a 12-year-old boy with CF who was admitted for an exacerbation which was unresponsive to antibiotic therapy. The findings on imaging raised concerns about a possible fungal infection. As a result, voriconazole therapy was started prior to his respiratory deterioration. He was later found to be β-D glucan and Aspergillus Ag galactomannan positive confirming the suspicion for invasive pulmonary aspergillosis. Three months after diagnosis, he was discharged home under stable condition. Voriconazole was continued beyond discharge and resulted in improvement of respiratory symptoms. This underscores the importance of early treatment of pulmonary aspergillosis in patients with CF. Unfortunately, the patient died 6 months after diagnosis from a CF exacerbation.

View Full Text

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.